COVID-19 treatment
Researchers have designed a synthetic defective SARS-CoV-2 virus that is innocuous but interferes with the
Researchers screened a panel of drugs that are already approved for clinical use and identified
Camillo Ricordi, M.D., director of the Diabetes Research Institute (DRI) and Cell Transplant Center at
SARS-CoV-2 infection in endothelial cells. For those with serious lung disease: Fighting Covid-19 symptoms using
via University of Pittsburgh School of Medicine Could llama nanobodies become a powerful weapon against
Biochemist Joanne Lemieux worked with three other U of A researchers on a new study
Stopping the growth of the coronavirus, leading to its eradication by the human host’s immune system
This figure shows that the incorporation of three nucleotide analogues Carbovir-5’-Triphosphate (Car-TP), Entecavir-5’-Triphosphate (Ent-TP), and
Journal cover. (Molecules) Can the coronavirus be prevented from invading a host cell? UC Riverside-led
via University of Cambridge Repurposing existing drugs offers a more rapid alternative to a vaccine
via Northwestern Researchers develop machine model that exponentially shortens expert review period Northwestern University researchers
A study volunteer who has recovered from COVID-19 donates blood at the Rockefeller University Hospital.
In cell cultures analyzed in the current study, hrsACE2 inhibited the coronavirus load by a
COVID-19 drug lead treatments identified Six drug candidates that may help treat COVID-19 An international
via The Scientist Magazine Blocking coronavirus infections using an engineered virus? Highlights: No vaccines exist
Professor Thomas Jaki and the city of Wuhan, China Positive signs from the first published